Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C9H6O3 |
| Molecular Weight | 162.1421 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1=CC2=C(OC1=O)C=CC=C2
InChI
InChIKey=MJKVTPMWOKAVMS-UHFFFAOYSA-N
InChI=1S/C9H6O3/c10-7-5-6-3-1-2-4-8(6)12-9(7)11/h1-5,10H
| Molecular Formula | C9H6O3 |
| Molecular Weight | 162.1421 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| In vivo indirect measurement of cytochrome P450-associated activities in freshwater gastropod molluscs. | 2010-12 |
|
| Structure-activity relationship of dihydroxy-4-methylcoumarins as powerful antioxidants: correlation between experimental & theoretical data and synergistic effect. | 2010-09 |
|
| Spatial regulation of membrane fusion controlled by modification of phosphoinositides. | 2010-08-17 |
|
| Development of pH-responsive fluorescent false neurotransmitters. | 2010-07-07 |
|
| Ketocoumarin dyes as electron mediators for visible light induced carboxylate photorelease. | 2010-06 |
|
| Engineering bacterial cytochrome P450 (P450) BM3 into a prototype with human P450 enzyme activity using indigo formation. | 2010-05 |
|
| Effects of Semelil (ANGIPARS™) on focal cerebral ischemia in male rats. | 2010 |
|
| Topical Calendula officinalis L. successfully treated exfoliative cheilitis: a case report. | 2009-11-23 |
|
| Comparison of intrinsic metabolic clearance in fresh and cryopreserved human hepatocytes. | 2009-09 |
|
| Study on the inhibitory mechanism and binding mode of the hydroxycoumarin compound NSC158393 to HIV-1 integrase by molecular modeling. | 2009-09 |
|
| 4-Hydr-oxy-3-[(2E)-3-(3,4,5-trimethoxy-phen-yl)prop-2-eno-yl]-2H-chromen-2-one. | 2009-06-20 |
|
| The structure-activity relationship between oxycoumarin derivatives showing inhibitory effects on iNOS in mouse macrophage RAW264.7 cells. | 2009-01 |
|
| Interaction of thyroxine with 7 hydroxycoumarin: a fluorescence quenching study. | 2008-09 |
|
| In vitro evaluation of reversible and irreversible cytochrome P450 inhibition: current status on methodologies and their utility for predicting drug-drug interactions. | 2008-06 |
|
| Multi-substrate flavonol O-glucosyltransferases from strawberry (Fragaria x ananassa) achene and receptacle. | 2008 |
|
| CYP2A6 polymorphisms: is there a role for pharmacogenomics in preventing coumarin-induced hepatotoxicity in lymphedema patients? | 2007-02 |
|
| 3-Hydroxycoumarin as a new matrix for matrix-assisted laser desorption/ionization time-of-flight mass spectrometry of DNA. | 2006-12 |
|
| Ethnopharmacological evaluation of radal (leaves of Lomatia hirsuta) and isolation of 2-methoxyjuglone. | 2006-08-31 |
|
| Influence of warfarin therapy on activated factor VII clotting activity. | 2006-04 |
|
| Lessons learned for the assessment of children's pesticide exposure: critical sampling and analytical issues for future studies. | 2005-10 |
|
| Antifungal synergistic effect of scopoletin, a hydroxycoumarin isolated from Melia azedarach L. fruits. | 2005-04-20 |
|
| Troxerutin protects the isolated perfused rat liver from a possible lipid peroxidation by coumarin. | 2005-01 |
|
| Antioxidant properties of 3-hydroxycoumarin derivatives. | 2004-11-01 |
|
| Convenient replacement of the hydroxy by an amino group in 4 hydroxycoumarin and 4-hydroxy-6-methyl-2-pyrone under microwave irradiation. | 2004-07-31 |
|
| Salmonella-based rodenticides and public health. | 2004-06 |
|
| Antineoplastic and antibacterial activity of some mononuclear Ru(II) complexes. | 2004-04 |
|
| Phase I and II enzyme characterization of two sources of HepG2 cell lines. | 2004-03 |
|
| Cloning and characterization of a glucosyltransferase that reacts on 7-hydroxyl group of flavonol and 3-hydroxyl group of coumarin from tobacco cells. | 2003-12-01 |
|
| Dermal absorption of a liquid diphacinone rodenticide causing coagulaopathy. | 2003-12 |
|
| Studies on the nitroreductase prodrug-activating system. Crystal structures of complexes with the inhibitor dicoumarol and dinitrobenzamide prodrugs and of the enzyme active form. | 2003-09-11 |
|
| PNA-based RNA-triggered drug-releasing system. | 2003-05-22 |
|
| High-affinity activators of cystic fibrosis transmembrane conductance regulator (CFTR) chloride conductance identified by high-throughput screening. | 2002-10-04 |
|
| Identification of the cytochromes P450 that catalyze coumarin 3,4-epoxidation and 3-hydroxylation. | 2002-05 |
|
| Excited-state dipole moments of some hydroxycoumarin dyes using an efficient solvatochromic method based on the solvent polarity parameter, EN(T). | 2001-01 |
|
| The phenolic acids of human urine; paper chromatography of phenolic acids. | 1956-01 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:16:16 GMT 2025
by
admin
on
Mon Mar 31 19:16:16 GMT 2025
|
| Record UNII |
RQX0CMD9PN
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
213-355-3
Created by
admin on Mon Mar 31 19:16:16 GMT 2025 , Edited by admin on Mon Mar 31 19:16:16 GMT 2025
|
PRIMARY | |||
|
DTXSID50239863
Created by
admin on Mon Mar 31 19:16:16 GMT 2025 , Edited by admin on Mon Mar 31 19:16:16 GMT 2025
|
PRIMARY | |||
|
74691
Created by
admin on Mon Mar 31 19:16:16 GMT 2025 , Edited by admin on Mon Mar 31 19:16:16 GMT 2025
|
PRIMARY | |||
|
939-19-5
Created by
admin on Mon Mar 31 19:16:16 GMT 2025 , Edited by admin on Mon Mar 31 19:16:16 GMT 2025
|
PRIMARY | |||
|
13650
Created by
admin on Mon Mar 31 19:16:16 GMT 2025 , Edited by admin on Mon Mar 31 19:16:16 GMT 2025
|
PRIMARY | |||
|
RQX0CMD9PN
Created by
admin on Mon Mar 31 19:16:16 GMT 2025 , Edited by admin on Mon Mar 31 19:16:16 GMT 2025
|
PRIMARY |